After controlling for age at diagnosis, race, study site, tumor stage, and histologic grade, no statistically significant association between the ER/PR/HER2 score and breast cancer-specific mortality risk was observed in women with ER-negative breast cancer (Table 4). Here, ERBB2 is linked to breast carcinoma.